Beneficial effects of novel aureobasidium pullulans strains produced beta-1,3-1,6 glucans on interleukin-6 and D-dimer levels in COVID-19 patients; results of a randomized multiple-arm pilot clinical study - Raghavan, Kadalraja; Dedeepiya, Vidyasagar Devaprasad; Suryaprakash, Vaddi; Rao, Kosagi-Sharaf; Ikewaki, Nobunao; Sonoda, Tohru; Levy, Gary A.; Iwasaki, Masaru; Senthilkumar, Rajappa; Preethy, Senthilkumar; Abraham, Samuel JK (Biomedicine & pharmacotherapy, 2022)
Keywords: Adjunct treatment; Aureobasidium; Beta glucans; beta-Glucans - administration & dosage; Biomarkers - blood; Coagulopathy; Complementary Therapies - methods; COVID-19; COVID-19 - blood; COVID-19 - diagnosis; COVID-19 Drug Treatment; Cytokine Release Syndrome - blood; Cytokine Release Syndrome - etiology; Cytokine Release Syndrome - prevention & control; Cytokine storm; D-dimer; Dietary Supplements; Female; Fibrin Fibrinogen Degradation Products - analysis; Humans; IL-6; Immuno-modulation; Immunologic Factors - administration & dosage; Interleukin-6 - analysis; Male; Middle Aged; Pilot Projects; SARS-CoV-2; Treatment Outcome; COVID-19; Adjunct treatment; D-dimer; Immuno-modulation; Cytokine storm; Beta glucans; IL-6; Coagulopathy